Pharmafile Logo
Pharmafocus logo
Advanced Search

avastin

Showing 15 posts of 94 posts found.

Roche to challenge FDA on Avastin

December 21, 2010
Sales and Marketing EMA, FDA, Roche, avastin, bevacizumab, breast cancer

Roche is set to challenge the decision by the FDA to remove a breast cancer indication from its blockbuster drug …

News
Avastin packs

NICE no for Avastin in breast cancer

December 8, 2010
Sales and Marketing NICE, Roche, avastin, bevacizumab, breast cancer, health technology assessment, hta

NICE has refused to back Roche’s Avastin for use in breast cancer patients citing the blockbuster drug’s high cost and …

News
Age-related macular degeneration (Wet AMD)

Bayer’s challenger to Lucentis shows promise

November 22, 2010
Research and Development, Sales and Marketing Bayer, Lucentis, Novartis, Regeneron, Roche, VEGF Trap-Eye, age-related macular degeneration, avastin, wet AMD

Phase III data for a new age-related macular degeneration (wet AMD) treatment show it is as good as Lucentis, the …

News
Roche job cuts

Roche set to cut 4,800 jobs worldwide

November 17, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Jobs, Roche, avastin, cuts, taspoglutide

Roche’s ‘Operational Excellence’ programme will see it cut 6% of its global workforce over the next two years. The initiative …

News
Avastin packs

NICE stands firm on Avastin rejection

November 12, 2010
Sales and Marketing NICE, Roche, avastin, bevacizumab, colon cancer, metastatic colorectal cancer, patient access scheme

NICE has refused to recommend Roche’s blockbuster cancer drug Avastin for the treatment of metastatic colorectal cancer in its final …

News

Avastin patient access scheme too complicated, says NICE

August 25, 2010
Sales and Marketing NICE, avastin, patient access

NICE is set to say no again to Avastin for use in patients with colorectal cancer. Avastin was first launched …

News
Avastin packs

FDA advised to halt Avastin breast cancer use

July 21, 2010
Sales and Marketing Roche, avastin

In a hammer blow to Roche, an influential Food and Drug Administration vote has gone against its cancer drug Avastin. …

News

Ovarian cancer trial boost for Avastin

July 5, 2010
Research and Development Roche, avastin, ovarian cancer

Roche’s blockbuster oncology drug Avastin has met its primary endpoint of improving progression-free survival in women with ovarian cancer in …

News

Avastin will remain gold standard for lung cancer to 2018

June 20, 2010
Decision Resources, NSCLC, Roche drug tipped to remain key to treatment, avastin

 Industry analysts Decision Resources believes that Roche’s Avastin plus chemotherapy agents will remain as the gold standard for the treatment …

News
Avastin packs

Avastin promising in ovarian cancer

June 7, 2010
Research and Development ASCO, avastin

Roche’s Avastin took a step closer to winning an additional indication after phase III trial data showed the blockbuster cancer …

News

Avastin study in ovarian cancer meets primary endpoint

February 25, 2010
Research and Development Cancer, avastin, ovarian

Preliminary results from a trial of Roche’s Avastin in advanced ovarian cancer suggest that the drug lengthens progression-free survival when …

News

Avastin fails in phase III study

February 24, 2010
Research and Development Roche, avastin, gastric cancer, stomach cancer

Roche’s Avastin does not help patients with a severe form of stomach cancer to live longer, according to the results …

News

Avastin shows promise in advanced breast cancer

August 20, 2009
Research and Development, Sales and Marketing Roche, avastin, breast cancer

Avastin's rise continues as new data suggests it improves progression-free survival as a second line treatment for advanced breast cancer.The …

News

Avastin gets US approval in kidney cancer

August 4, 2009
Research and Development, Sales and Marketing Roche, US, avastin

Roche's rising star Avastin has won US approval to treat the most common type of kidney cancer, the latest in …

News

Avastin approved for aggressive brain tumour

May 7, 2009
Sales and Marketing GBM, avastin

 Roche has gained US approval for Avastin in people with the aggressive brain cancer glioblastoma multiforme (GBM). The drug can …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024